Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Nature Communications
|
March 23, 2023
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
Crismita Dmello, Junfei Zhao, Li Chen, et al.
Nature Communications
|
January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier, Michael C Brown, Gao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence
Margaret Johnson, April Bell, Kristen L Lauing, et al.
Nature Cancer
|
April 2, 2021
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Koichi Oshima, Junfei Zhao, Pablo Pérez-Durán, et al.
Neuro-Oncology
|
July 19, 2024
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
Kwang-Soo Kim, Karl Habashy, Andrew Gould, et al.
Neuro-Oncology
|
January 26, 2026
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity
Victor A Arrieta, J Kada Benotmane, Rebecca Du, et al.
Cancer Cell
|
March 28, 2025
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
Ioanna Mosialou, Abdullah M Ali, Rossella Labella, et al.
Cell Metabolism
|
December 22, 2023
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Aida Rashidi, Leah K Billingham, Andrew Zolp, et al.
Nature Cancer
|
February 12, 2022
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Víctor A Arrieta, Andrew X Chen, J Robert Kane, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
A transposase-derived gene required for human brain development
Luz Jubierre Zapater, Sara A Lewis, Rodrigo Lopez Gutierrez, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Nature Communications
|
March 23, 2023
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
Crismita Dmello, Junfei Zhao, Li Chen, et al.
Nature Communications
|
January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier, Michael C Brown, Gao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence
Margaret Johnson, April Bell, Kristen L Lauing, et al.
Nature Cancer
|
April 2, 2021
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Koichi Oshima, Junfei Zhao, Pablo Pérez-Durán, et al.
Neuro-Oncology
|
July 19, 2024
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
Kwang-Soo Kim, Karl Habashy, Andrew Gould, et al.
Neuro-Oncology
|
January 26, 2026
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity
Victor A Arrieta, J Kada Benotmane, Rebecca Du, et al.
Cancer Cell
|
March 28, 2025
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
Ioanna Mosialou, Abdullah M Ali, Rossella Labella, et al.
Cell Metabolism
|
December 22, 2023
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Aida Rashidi, Leah K Billingham, Andrew Zolp, et al.
Nature Cancer
|
February 12, 2022
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Víctor A Arrieta, Andrew X Chen, J Robert Kane, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
A transposase-derived gene required for human brain development
Luz Jubierre Zapater, Sara A Lewis, Rodrigo Lopez Gutierrez, et al.
Page
of 12